Pharmaceuticals & Biotechnology

Alto Neuroscience, Inc. CEO pay

Amit Etkin, M.D., Ph.D. President, Chief Executive Officer, and Chair of the Board. Fiscal year 2025, as reported to the SEC.

Total compensation

$2.2M

$2,188,487 for fiscal 2025: the Summary Compensation Table total, with stock and option awards at their grant-date value.

Definitive proxy statement, filed 2026-03-26SEC accession number 0001104659-26-035180

In context

The median chief executive among 465 Pharmaceuticals & Biotechnology companies was paid $2.2M. The middle half ranged from $1M to $4.9M.

Amit Etkin's total is at that median.

See how your pay compares to Alto Neuroscience, Inc.'s peers

CEOSalary breaks this total into salary, bonus, stock and option awards, builds a peer set of comparable companies around it, and places your own package against them, with every figure cited to its filing.

Start a 3-day trial

Source: Alto Neuroscience, Inc.'s definitive proxy statement (SEC Form DEF 14A), Summary Compensation Table, fiscal year 2025. Figures are as reported by the company and are not adjusted or estimated. Context figures are from CEOSalary's snapshot of SEC filings as of 2026-10-28. Not financial, legal or compensation-consulting advice.